Table 4.
Total cohort tumor detection rates using imaging screening by history of prior PGL/PCC.
| HCI | U of M | Penn | TOTAL | Percent | |
|---|---|---|---|---|---|
| Subjects without prior history of PGL/PCC, n | 83 | 59 | 52 | 194 | 74% (194/263) |
| Subjects with screen positive SDHx-related tumor, n | 18 | 7 | 11 | 36 | 19% (36/194) |
| Subjects with recurrence of SDHx-related tumor on screen, n | 0 | 0 | 1 | 1 | .. |
| Subjects with false positive screen for SDHx-related tumors, n | 0 | 2 | 0 | 2 | .. |
| Subjects with indeterminate finding for SDHx-related tumors, n | 1 | 0 | 0 | 1 | .. |
| Subjects with prior history of PGL/PCC, n | 17 | 36 | 16 | 69 | 26% (69/263) |
| Subjects with screen positive SDHx-related tumor, n | 6 | 1 | 2 | 9 | 13% (9/69) |
| Subjects with recurrence of SDHx-related tumor on screen, n | 1 | 0 | 1 | 2 | .. |
| Subjects with false positive screen for SDHx-related tumors, n | 0 | 2 | 0 | 2 | .. |
| Subjects with indeterminate finding for SDHx-related tumors, n | 0 | 1 | 0 | 1 | .. |
| Total subjects with positive screen for SDHx-related tumor, n | 24 | 8 | 13 | 45 | 17% (45/263) |
HCI: Huntsman Cancer Institute; U of M: University of Michigan; Penn: University of Pennsylvania